STAT September 26, 2023
Sarah Owermohle

You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays.

Does the shutdown actually stall price negotiations?

There are a slew of government health programs and thousands of federal staff that could see work stalled by the budget deadline Friday. But is Biden’s signature drug pricing program on the outs too?

HHS Secretary Xavier Becerra warned reporters Friday that “a lot” of the work negotiation staff are doing right now — compiling information, corresponding with manufacturers — “takes people who would be impacted by a shutdown.”

Except … the Inflation Reduction Act provisioned $3 billion for the negotiation program to get up and running. Unless Medicare has already...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
What to know about Trump's surgeon general nominee
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Trump's pick for CDC director: 10 things to know
STAT+: Minnesota becomes first state to release report on 340B drug discount program for ‘safety-net’ hospitals
Trump tariffs could drive up generic drug costs: 5 takeaways

Share This Article